HerzPub Date : 2024-06-01Epub Date: 2024-05-06DOI: 10.1007/s00059-024-05246-1
Jürgen Kuschyk, Katherine Sattler, Fabian Fastenrath, Boris Rudic, Ibrahim Akin
{"title":"[Treatment with cardiac electronic implantable devices].","authors":"Jürgen Kuschyk, Katherine Sattler, Fabian Fastenrath, Boris Rudic, Ibrahim Akin","doi":"10.1007/s00059-024-05246-1","DOIUrl":"10.1007/s00059-024-05246-1","url":null,"abstract":"<p><p>Cardiac device therapy provides not only treatment options for bradyarrhythmia but also advanced treatment for heart failure and preventive measures against sudden cardiac death. In heart failure treatment it enables synergistic reverse remodelling and reduces pharmacological side effects. Cardiac resynchronization therapy (CRT) has revolutionized the treatment of reduced left ventricular ejection fraction (LVEF) and left bundle branch block by decreasing the mortality and morbidity with improvement of the quality of life and resilience. Conduction system pacing (CSP) as an alternative method of physiological stimulation can improve heart function and reduce the risk of pacemaker-induced cardiomyopathy. Leadless pacers and subcutaneous/extravascular defibrillators offer less invasive options with lower complication rates. The prevention of infections through preoperative and postoperative strategies enhances the safety of these therapies.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"233-246"},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-06-01Epub Date: 2024-03-11DOI: 10.1007/s00059-024-05241-6
Martin Möckel
{"title":"The new ESC acute coronary syndrome guideline and its impact in the CPU and emergency department setting.","authors":"Martin Möckel","doi":"10.1007/s00059-024-05241-6","DOIUrl":"10.1007/s00059-024-05241-6","url":null,"abstract":"<p><p>The new guideline on acute coronary syndrome (ACS) of the European Society of Cardiology (ESC) replaces two separate guidelines on ST-elevation myocardial infarction (STEMI) and non-ST-elevation (NSTE) ACS. This change of paradigm reflects the experts view that the ACS is a continuum, starting with unstable angina and ending in cardiogenic shock or cardiac arrest due to severe myocardial ischemia. Secondary, partly non-atherosclerotic-caused myocardial infarctions (\"type 2\") are not integrated in this concept.With respect to acute care in the setting of emergency medicine and the chest pain unit structures, the following new aspects have to be taken into account:1. New procedural approach as \"think A.C.S.\" meaning \"abnormal ECG,\" \"clinical context,\" and \"stable patient\"2. New recommendation regarding a holistic approach for frail patients3. Revised recommendations regarding imaging and timing of invasive strategy in suspected NSTE-ACS4. Revised recommendations for antiplatelet and anticoagulant therapy in STEMI5. Revised recommendations for cardiac arrest and out-of-hospital cardiac arrest6. Revised recommendations for in-hospital management (starting in the CPU/ED) and ACS comorbid conditionsIn summary, the changes are mostly gradual and are not based on extensive new evidence, but more on focused and healthcare process-related considerations.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"185-189"},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140101444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-06-01Epub Date: 2024-05-29DOI: 10.1007/s00059-024-05243-4
Frank Breuckmann
{"title":"[Acute chest pain in transition : New definitions, new standards and new developments].","authors":"Frank Breuckmann","doi":"10.1007/s00059-024-05243-4","DOIUrl":"https://doi.org/10.1007/s00059-024-05243-4","url":null,"abstract":"","PeriodicalId":12863,"journal":{"name":"Herz","volume":"49 3","pages":"165-166"},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-06-01Epub Date: 2023-10-17DOI: 10.1007/s00059-023-05210-5
Anar Aghayev, Mattes Hinnerichs, Andreas Wienke, Hans-Jonas Meyer, Alexey Surov
{"title":"Epicardial adipose tissue as a prognostic marker in acute pulmonary embolism.","authors":"Anar Aghayev, Mattes Hinnerichs, Andreas Wienke, Hans-Jonas Meyer, Alexey Surov","doi":"10.1007/s00059-023-05210-5","DOIUrl":"10.1007/s00059-023-05210-5","url":null,"abstract":"<p><strong>Background: </strong>Epicardial adipose tissue (EAT) has been established as a quantitative imaging biomarker associated with disease severity in coronary heart disease. Our aim was to use this prognostic marker derived from computed tomography pulmonary angiography (CTPA) for the prediction of mortality and prognosis in patients with acute pulmonary embolism.</p><p><strong>Methods: </strong>The clinical database was retrospectively screened for patients with acute pulmonary embolism between 2015 and 2021. Overall, 513 patients (216 female, 42.1%) were included in the analysis. The study end-point was 30-day mortality. Epicardial adipose tissue was measured on the diagnostic CTPA in a semiquantitative manner. The volume and density of EAT were measured for every patient.</p><p><strong>Results: </strong>Overall, 60 patients (10.4%) died within the 30-day observation period. The mean EAT volume was 128.3 ± 65.0 cm<sup>3</sup> in survivors and 154.6 ± 84.5 cm<sup>3</sup> in nonsurvivors (p = 0.02). The density of EAT was -79.4 ± 8.3 HU in survivors and -76.0 ± 8.4 HU in nonsurvivors (p = 0.86), and EAT density was associated with 30-day mortality (odds ratio [OR] = 1.07; 95% confidence interval [CI]: 1.03; 1.1, p < 0.001) but did not remain statistically significant in multivariable analysis. No association was identified between EAT volume and 30-day mortality (OR = 1.0; 95% CI: 1.0; 1.0, p = 0.48).</p><p><strong>Conclusion: </strong>There might be an association between EAT density and mortality in patients with acute pulmonary embolism. Further studies are needed to elucidate the prognostic relevance of EAT parameters in patients with acute pulmonary embolism.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"219-223"},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41234616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-06-01Epub Date: 2023-10-19DOI: 10.1007/s00059-023-05211-4
A Schuch, P Walther, L Timm, K Steinbach, L Haneklaus, T Münzel, J H Prochaska, P S Wild
{"title":"[Utilization of video consultation in cardiovascular lipid treatment].","authors":"A Schuch, P Walther, L Timm, K Steinbach, L Haneklaus, T Münzel, J H Prochaska, P S Wild","doi":"10.1007/s00059-023-05211-4","DOIUrl":"10.1007/s00059-023-05211-4","url":null,"abstract":"<p><strong>Background: </strong>Video consultation is a possibility for physician-patient communication independent of the location; however, only limited information is available for the possibility of sole use since 2018.</p><p><strong>Methods: </strong>After the implementation of video consultation (Viomedi) in lipid consultations at the Medical University Mainz, the patients in the first quarter of 2022 were assessed depending on the possibility, suitability and readiness to participate. Included were patients under lipid management and long COVID patients. After treatment an online survey was carried out on the utilization and appraisal.</p><p><strong>Results: </strong>Of the 134 patients 29.1% were inclusively treated (3 refusals). All subjects (16 replies) reported having managed (very) well. Advantages were seen in counselling and follow-up. Problems were feared with respect to technology and possible disorders. Data protection aspects played a subordinate role. In comparison to telephone calls, a significant improvement in the physician-patient relationship (p-value = 0.00027), the quality of treatment and information (p-value both = 0.00044), the access to care (p-value = 0.0053) and the communication (p-value = 0.021) was assumed. An improvement in access to care (p-value = 0.021) and the quality of information (p-value = 0.034) was seen in comparison to personal contact. The main problems were a lack of experience, technical requirements, technical problems and unpunctuality of the practitioner. The flexibility, low effort and the pleasant consultation were all praised. All subjects wanted to use the video consultation again.</p><p><strong>Conclusion: </strong>Video consultation can represent a supplement to treatment of patients under lipid management. The correct use requires exact planning and further research.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"224-232"},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11136760/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49676803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-06-01Epub Date: 2023-10-03DOI: 10.1007/s00059-023-05209-y
Martin Sigl, Stefan Baumann, Ann-Sophie Könemann, Michael Keese, Kay Schwenke, Andreas L H Gerken, Daniel Dürschmied, Stephanie Rosenkaimer
{"title":"Prognostic value of extended cardiac risk assessment before elective open abdominal aortic surgery.","authors":"Martin Sigl, Stefan Baumann, Ann-Sophie Könemann, Michael Keese, Kay Schwenke, Andreas L H Gerken, Daniel Dürschmied, Stephanie Rosenkaimer","doi":"10.1007/s00059-023-05209-y","DOIUrl":"10.1007/s00059-023-05209-y","url":null,"abstract":"<p><strong>Background: </strong>Major vascular surgery is associated with a high perioperative risk and significant mortality. Despite advances in risk stratification, monitoring, and management of perioperative complications, cardiac complications are still common. Stress echocardiography is well established in coronary artery disease diagnostics; however, its prognostic value before high-risk aortic surgery is unknown. This prospective, single-center study compared the outcome of patients undergoing extended cardiac risk assessment before open abdominal aortic surgery with the outcome of patients who had received standard preoperative assessment.</p><p><strong>Methods: </strong>The study included patients undergoing elective open abdominal aortic surgery. Patients who underwent standard preoperative assessment before the start of a dedicated protocol were compared with patients who had extended cardiac risk assessment, including dobutamine stress echocardiography, as part of a stepwise interdisciplinary cardiovascular team approach. The combined primary endpoint was cardiovascular death, myocardial infarction, emergency coronary revascularization, and life-threatening arrhythmia within 30 days. The secondary endpoint was acute renal failure and severe bleeding.</p><p><strong>Results: </strong>In total, 77 patients (mean age 68.1 ± 8.1 years, 70% male) were included: 39 underwent standard and 38 underwent cardiac risk assessment. The combined primary endpoint was reached significantly more often in patients before than after implementation of the extended cardiac stratification procedure (15% vs. 0%, p = 0.025). The combined secondary endpoint did not differ between the groups.</p><p><strong>Conclusions: </strong>Patients with extended cardiac risk assessment undergoing elective open abdominal aortic surgery had better 30-day outcomes than did those who had standard preoperative assessment.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"210-218"},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41117858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Novel biomarkers identified by weighted gene co-expression network analysis for atherosclerosis.","authors":"Jiajun Ni, Kaijian Huang, Jialin Xu, Qi Lu, Chu Chen","doi":"10.1007/s00059-023-05204-3","DOIUrl":"10.1007/s00059-023-05204-3","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to screen out the potential diagnostic biomarkers for atherosclerosis (AS).</p><p><strong>Methods: </strong>We downloaded the gene expression profiles GSE66360, GSE28829, GSE41571, GSE71226, and GSE100927 from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) were identified using the \"limma\" package in R. Weighted gene co-expression network analysis (WGCNA) was applied to reveal the correlation between genes in different samples. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed. The interaction pairs of proteins were retained by the STRING database, and the protein-protein interaction (PPI) network was visualized with the hub genes. Finally, the R packages \"ggpubr\" and \"preprocessCore\" were used to analyze immune cell infiltration.</p><p><strong>Results: </strong>In total, 40 overlapping genes both in GSE66360 and GSE28829 were found to be related to the occurrence of AS. Further, the top 10 network hub genes including TYROBP, CSF1R, TLR2, CD14, CCL4, FCER1G, CD163, TREM1, PLEK, and C5AR1 were identified as significant key genes. Moreover, four genes (TYROBP, CSF1R, FCGR1B, and CD14) were verified that could efficiently diagnose AS. Finally, the gene TYROBP was found to have a strong correlation with immune-infiltrating cells.</p><p><strong>Conclusion: </strong>Our study identified four genes (TYROBP, CSF1R, FCGR1B, and CD14) that may be effective biomarkers for AS, with the potential to guide the clinical diagnosis of AS.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"198-209"},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10287604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-06-01Epub Date: 2024-03-01DOI: 10.1007/s00059-024-05240-7
Stephan Settelmeier, Sebastian Steven, Felix Post, Ingo Ahrens, Evangelos Giannitsis, Frank Breuckmann
{"title":"New categorization of chest pain: noncardiac is in, atypical is out!","authors":"Stephan Settelmeier, Sebastian Steven, Felix Post, Ingo Ahrens, Evangelos Giannitsis, Frank Breuckmann","doi":"10.1007/s00059-024-05240-7","DOIUrl":"10.1007/s00059-024-05240-7","url":null,"abstract":"<p><p>Chest pain poses a diagnostic challenge in the emergency department and requires a thorough clinical assessment. The traditional distinction between \"atypical\" and \"typical\" chest pain carries the risk of not addressing nonischemic clinical pictures. The newly conceived subdivision into cardiac, possibly cardiac, and (probably) noncardiac causes of the presenting symptom complex addresses a much more interdisciplinary approach to a symptom-oriented diagnostic algorithm. The diagnostic structures of the chest pain units in Germany do not currently reflect this. An adaptation should therefore be considered.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"181-184"},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139996047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-06-01Epub Date: 2023-12-28DOI: 10.1007/s00059-023-05230-1
Sebastian Imhof, Matthias Hochadel, Stavros Konstantinides, Thomas Voigtländer, Claus Schmitt, Bernd Nowak, Tienush Rassaf, Jochen Senges, Thomas Münzel, Evangelos Giannitsis, Frank Breuckmann
{"title":"Cardiac, possible cardiac, and likely non-cardiac origin of chest pain : A hitherto underestimated parameter in German chest pain units.","authors":"Sebastian Imhof, Matthias Hochadel, Stavros Konstantinides, Thomas Voigtländer, Claus Schmitt, Bernd Nowak, Tienush Rassaf, Jochen Senges, Thomas Münzel, Evangelos Giannitsis, Frank Breuckmann","doi":"10.1007/s00059-023-05230-1","DOIUrl":"10.1007/s00059-023-05230-1","url":null,"abstract":"<p><strong>Background: </strong>Current guidelines emphasize the diagnostic value of non-cardiac or possibly cardiac chest pain. The goal of this analysis was to determine whether German chest pain units (CPUs) adequately address conditions with \"atypical\" chest pain in existing diagnostic structures.</p><p><strong>Method: </strong>A total of 11,734 patients from the German CPU registry were included. The analyses included mode of admission, critical time intervals, diagnostic steps, and differential diagnoses.</p><p><strong>Results: </strong>Patients with unspecified chest pain were younger, more often female, were less likely to have classic cardiovascular risk factors and tended to present more often as self-referrals. Patients with acute coronary syndrome (ACS) mostly had prehospital medical contact. Overall, there was no difference between these two groups regarding the time from the onset of first symptoms to arrival at the CPU. In the CPU, the usual basic diagnostic measures were performed irrespective of ACS as the primary working diagnosis. In the non-ACS group, further ischemia-specific diagnostics were rarely performed. Extra-cardiac differential diagnoses were not specified.</p><p><strong>Conclusion: </strong>The establishment of broader awareness programs and opening CPUs for low-threshold evaluation of self-referring patients should be discussed. Regarding the rigid focus on the clarification of cardiac causes of chest pain, a stronger interdisciplinary approach should be promoted.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"175-180"},"PeriodicalIF":1.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139058227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-05-07DOI: 10.1007/s00059-024-05249-y
Muhammad Umair Javaid, Muhammad Ikrama, Shafqat Abbas, Muhammad Saad Javaid, Muhammad Danial Khalid, Nabeel Riaz, Malik Ahsan Safdar
{"title":"Exploring Roemheld syndrome: a comprehensive review with proposed diagnostic criteria.","authors":"Muhammad Umair Javaid, Muhammad Ikrama, Shafqat Abbas, Muhammad Saad Javaid, Muhammad Danial Khalid, Nabeel Riaz, Malik Ahsan Safdar","doi":"10.1007/s00059-024-05249-y","DOIUrl":"https://doi.org/10.1007/s00059-024-05249-y","url":null,"abstract":"<p><p>Roemheld syndrome (RS) is a condition that triggers cardiac symptoms due to gastrointestinal compression of the heart. It is often misdiagnosed as other types of cardiac or digestive disorders, leading to unnecessary treatments and reduced quality of life. Here, we provide a thorough review of RS, covering its pathogenesis, etiology, diagnosis, treatment, and outcome. We found that a number of conditions, including gallstones, hiatal hernia, excessive gas, and gastroesophageal reflux syndrome, can cause RS. The symptoms of RS can include chest pain, palpitations, shortness of breath, nausea, vomiting, bloating, and abdominal pain. Clinical history, physical examination, electrocardiograms, and improvement in symptoms following gastrointestinal therapy can all be used to identify RS. We also propose a set of criteria, the IKMAIR criteria, to improve the diagnostic approach for this condition. Dietary changes, lifestyle adjustments, pharmaceutical therapies, and surgical procedures can all be used to control RS. Depending on the underlying etiology and the outcome of treatment, RS has a varying prognosis. We conclude that RS is a complicated and understudied disorder that needs more attention from researchers and patients as well as from medical professionals. We recommend the inclusion of RS in the differential diagnosis for individuals with gastrointestinal problems and unexplained cardiac symptoms. Additionally, we advise treating RS holistically by attending to its cardiac and gastrointestinal components.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140876300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}